/ NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /
Originally published via Source Article.
/ NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /
Originally published via Source Article.
/ NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /
Originally published via Source Article.
/ NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /
Originally published via Source Article.
Gross proceeds of ~A$180M (before costs)
Gross proceeds of ~A$180M (before costs)
Originally published via Source Article.
Gross proceeds of ~A$180M (before costs)
Gross proceeds of ~A$180M (before costs)
Originally published via Source Article.
Gross proceeds of ~A$180M (before costs)
Gross proceeds of ~A$180M (before costs)
Originally published via Source Article.
Gross proceeds of ~A$180M (before costs)
Gross proceeds of ~A$180M (before costs)
Originally published via Source Article.
Gross proceeds of ~A$180M (before costs)
Gross proceeds of ~A$180M (before costs)
Originally published via Source Article.
Gross proceeds of ~A$180M (before costs)
Gross proceeds of ~A$180M (before costs)
Originally published via Source Article.
TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, announced today that management will participate in the Lake Street Capital Markets “BIG10” Conference on September 10, 2026 in New York City.
Originally published via Source Article.